Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Cogent Biosciences Inc’s stock clocked out at $16.57, up 7.39% from its previous closing price of $15.43. In other words, the price has increased by $7.39 from its previous closing price. On the day, 2.08 million shares were traded. COGT stock price reached its highest trading level at $16.58 during the session, while it also had its lowest trading level at $15.2601.
Ratios:
To gain a deeper understanding of COGT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.19 and its Current Ratio is at 4.19. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Raymond James on September 03, 2025, initiated with a Strong Buy rating and assigned the stock a target price of $30.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $17.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 10 ’25 when Fairmount Funds Management LLC bought 2,777,777 shares for $9.00 per share. The transaction valued at 24,999,993 led to the insider holds 9,003,418 shares of the business.
Pinnow Cole bought 43,750 shares of COGT for $332,412 on Jan 14 ’25. The Chief Commercial Officer now owns 45,848 shares after completing the transaction at $7.60 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COGT now has a Market Capitalization of 2314842112 and an Enterprise Value of 2246798080.
Stock Price History:
The Beta on a monthly basis for COGT is 0.39, which has changed by 0.32560134 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, COGT has reached a high of $16.99, while it has fallen to a 52-week low of $3.72. The 50-Day Moving Average of the stock is 26.55%, while the 200-Day Moving Average is calculated to be 87.46%.
Shares Statistics:
It appears that COGT traded 1.86M shares on average per day over the past three months and 2051510 shares per day over the past ten days. A total of 113.93M shares are outstanding, with a floating share count of 112.56M. Insiders hold about 19.43% of the company’s shares, while institutions hold 87.65% stake in the company. Shares short for COGT as of 1759190400 were 17011048 with a Short Ratio of 9.13, compared to 1756425600 on 13067172. Therefore, it implies a Short% of Shares Outstanding of 17011048 and a Short% of Float of 13.819999999999999.
Earnings Estimates
Cogent Biosciences Inc (COGT) is presently subject to a detailed evaluation by 12.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.37 and low estimates of -$0.59.
Analysts are recommending an EPS of between -$1.85 and -$2.42 for the fiscal current year, implying an average EPS of -$2.2. EPS for the following year is -$1.84, with 12.0 analysts recommending between -$0.98 and -$2.41.
